Objectives As clinical trials for psychedelic compounds continue the transition from safety-
and feasibility-testing to evaluating efficacy, the role of the accompanying psychotherapy …

Psychedelic drug therapy has gained prominence for its potential in treating various mental
health conditions, including depression, post-traumatic stress disorder (PTSD), and anxiety …

Psychedelics, as a class of potent psychoactive substances, significantly alter sensory
perception and mood, thereby profoundly impacting cognition. Increasing evidence …

Tackling sustainability issues requires engagement with inner dimensions of sustainability,
including the beliefs, values, worldviews and paradigms that influence how people perceive …

Although psychedelic and hallucinogenic substances have gained popularity for therapeutic
use, their dermatologic adverse effects are poorly characterized. This review characterizes …

Background Psychedelic drugs are increasingly visible in society once more, but their risks
and adverse effects have received less attention than perhaps they should. While fatalities …

Although research on psychedelic-assisted therapy (PAT) is rapidly expanding, the clinical
trial literature has been criticized for its underrepresentation of sexual and gender minority …

Psychedelics, including ketamine, 3, 4-Methyl enedioxy methamphetamine (MDMA), and
psilocybin, have gained attention for their potential therapeutic role in mental health …

Background Numerous clinical trials have supported psychedelic-assisted therapy (PAT) as
a treatment for psychiatric disorders such as depression, anxiety, post-traumatic stress, and …

Although several studies have well described the characteristics of people who use
psychedelics alongside their motivations and beliefs, little research has examined the …